NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

InDevR Inc.

Business Name: InDevR Inc.
Business Genre:
Business Description:

Biotech company in progressive new analytical technologies that help accelerate vaccine development and other biotherapeutics [1]

City: Boulder
State: CO
Country: USA
Data/Evidence of Effectiveness: No data, sent out for clinical validation in April [3]
Complimentary Products Needed to Perform Test: Not listed, but maybe similar to other VaxArray based methods. Need the VaxArray machine [2]
Setting of Care: Should be in clinical lab settings
Current Status / Clinical Development Stage / Expected Milestones: Still in development, in clinical validation phase [3], would need to obtain EUA
Funding & Ownership : Early stage venture, Private (less than 1M)
Business Model: Sell their VaxAssay systems to companies that are interested in vaccine development. Their platform claims to simplify and accelerate the potency test for potential vaccine targets. [4]
IP: Numerous patents about their VasAssay systems and other panels [6]
History & Origins : Company was established in 2003 with numerous awards for the new companies. They specialized in their detection platforms that could help accelerate the development of vaccines. Already established several platforms including influenza. [4][6]
Date EUA Issued: Still in development, sent out kit for clinical validation [3]
Sources: “[1] https://indevr.com/about-us/ [2] https://indevr.com/products/vaxarray/vaxarray-coronavirus-seroassay-kits/ [3] https://indevr.com/2020/04/indevr-ships-first-multiplexed-covid-19-serology-test-kits-clinical-validation/ [4] https://indevr.com/products/vaxarray/ [5] https://www.crunchbase.com/organization/indevr#section-overview [6] https://indevr.com/about-us/leadership-team/”
Organization: Kathy Rowlen (CEO), Erica Dawson (CTO) [6]
No. Tests Per Day: ~100 samples/ day
Time to Result: Under 2 hours for a run, can process ~100 samples/ day [2]
Test Sample Type: blood sample [2]
Technology Overview: Similar to ELISA based methods. A multiplex immunoassay that a panel of antigens is coated in the microarray to capture the CoV-2 related antibodies. The platform is a high-throughput (~100/day) and automated method to detect CoV-2 antibodies. [2]
Testing Type: Serology antibody test [2]
Test Category: SEROLOGY
Test Name: COVID Serology Kit: Multiplexed Immunoassay
Clinical Application & Need: Immunity, vaccine development [2]
Age of Company: 2003

Send Message to listing owner